8 recruiting, 5 completed, 2 not yet recruiting, 1 active not recruiting. 5 Not applicable, 5 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 5 | Completed 3, Recruiting 2 |
| Phase 2 | 5 | Recruiting 3, Completed 2 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Long COVID Syndrome: new trials by email Literature Review of Long COVID Syndrome trials Research Report on Long COVID Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dapagliflozin for Long COVID Syndrome Dapagliflozin (DAPA), Placebo - COVID - 19, Long COVID Syndrome | Phase 3 | Not yet recruiting | Ottawa Heart Institute Research Corporation | 192 | 2026-09-01 | 2026-07-01 |
| Micro-choice-based Intervention for Multicausal Fatigue Micro-choice-based intervention - Multicausal Fatigue, Fatigue | Not applicable | Recruiting | University Hospital, Basel, Switzerland | 24 | 2026-08-13 | 2026-08-18 |
| Observational Study of Intranasal IVIG in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Patients Undergoing Medical Tourism Post-Acute Sequelae of SARS-CoV-2 Infection, Long COVID | Not yet recruiting | Tamara C Tamas | 50 | 2026-08-01 | 2025-12-02 | |
| Diaphragmatic Breathing Exercises With KOTS Currents in Patients With Long COVID Diaphragmatic Electrostimulation Using KOTS Currents, Diaphragmatic Breathing Exercises - Long COVID Syndrome, Post-Acute COVID-19 Syndrome | Not applicable | Completed | Universidad Pontificia de Salamanca | 9 | 2026-06-14 | 2026-09-29 |
| Does Taurine Supplementation Improve Vascular Function and Orthostatic Responses in Long COVID? Taurine supplementation - Long COVID Syndrome | Recruiting | York University | 30 | 2026-06-01 | 2026-06-05 | |
| Immunoadsorption in Autoimmune Long COVID Immunoadsorption, Sham Comparator - Long COVID, Long COVID Syndrome | Phase 2 | Recruiting | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 70 | 2026-01-01 | 2026-01-05 |
| A Study to Examine Anktiva for the Treatment of COVID-19. Anktiva - Long COVID, Long COVID Syndrome | Phase 2 | Recruiting | ImmunityBio, Inc. | 40 | 2025-09-04 | 2026-09-24 |
| Magnetic Resonance Analysis of Neural Inflammatory Factors and External Stimulation accelerated intermittent theta burst stimulation - Long COVID, Long COVID Syndrome | Phase 2 | Recruiting | University of New Mexico | 60 | 2025-07-07 | 2026-07-15 |
| Osteopathic Manipulative Therapy Effects on Post-Acute Sequelae of COVID-19 (PASC) or Long COVID Osteopathic Manipulative Therapy Long-COVID protocol, Osteopathic Manipulative Therapy NOT Long-COVID treatment protocol - Long-COVID, PASC | Not applicable | Recruiting | University of Louisville | 20 | 2025-05-01 | 2025-03-19 |
| A Fasting Pilot Study for Long COVID prolonged fasting - Long COVID Syndrome | Not applicable | Completed | Université de Sherbrooke | 25 | 2025-05-01 | 2026-02-18 |
| Effectiveness of a Personalized In-home Telerehabilitation Program on Self-Care in Patients With Long COVID Education for self-management, Personalised exercise program, Usual Care - Long COVID Syndrome | Phase 2 | Completed | CEU San Pablo University | 57 | 2025-03-01 | 2026-10-08 |
| Evaluation of MicroRNAs and Vitamin B12 Expression in Subjects with Neurologic Symptoms of Depression, Anxiety and Fatigue in Long COVID-19 Long COVID, Long COVID Syndrome | Recruiting | Instituto Nacional de Rehabilitacion | 20 | 2025-02-18 | 2025-03-07 | |
| Study to Evaluate the Efficacy and Safety of Plitidepsin in Adults With Post-COVID-19 Condition (PCC) Plitidepsin 1.5 mg/day, Placebo, Placebo and Plitidepsin 1.5mg/day - Post COVID-19 Condition, Long COVID Syndrome | Phase 2 | Completed | Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | 90 | 2025-02-07 | 2026-10-08 |
| Feasibility and Preliminary Efficacy of a Group-based Telerehabilitation Program in People With Post-COVID-19 Sequelae (TEPCO). Rehabilitation program - Long COVID-19 Syndrome, Long COVID | Not applicable | Completed | Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec | 22 | 2023-04-07 | 2025-04-30 |
| Characteristics of Long COVID-19 Syndrome No intervention - Long COVID Syndrome | Active not recruiting | Christian Clarenbach | 200 | 2021-02-23 | 2025-03-30 | |
| IMPRoving Cardiovascular RiSk Stratification Using T1 Mapping in General populatION Cardiac Imaging - Myocarditis, Heart Failure | Recruiting | Johann Wolfgang Goethe University Hospital | 6000 | 2016-11-15 | 2026-01-06 |
Post-Acute COVID-19 Syndrome (14) · COVID-19 (3) · Fatigue (2) · Anxiety Disorders (1) · Depression (1) · Fasting (1) · Fatigue Syndrome, Chronic (1) · Heart Failure (1) · Inflammation (1) · Mental Fatigue (1) · Motor Activity (1) · Myocarditis (1)
Coronaviridae Infections (15) · Coronavirus Infections (15) · Infections (15) · Lung Diseases (15) · Nidovirales Infections (15) · Pathologic Processes (15) · Pathological Conditions, Signs and Symptoms (15) · Pneumonia (15) · Pneumonia, Viral (15) · RNA Virus Infections (15) · Respiratory Tract Diseases (15) · Respiratory Tract Infections (15) · Virus Diseases (15) · Chronic Disease (14) · Disease Attributes (14)
ALT-803 (1) · Educational Status (1) · Plasmapheresis (1) · Rehabilitation (1) · Self-Management (1) · dapagliflozin (1) · plitidepsin (1)
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · CEU San Pablo University (1) · Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec (1) · Christian Clarenbach (1) · Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia (1) · ImmunityBio, Inc. (1) · Instituto Nacional de Rehabilitacion (1) · Johann Wolfgang Goethe University Hospital (1) · Ottawa Heart Institute Research Corporation (1) · Tamara C Tamas (1) · Universidad Pontificia de Salamanca (1) · University Hospital, Basel, Switzerland (1) · University of Louisville (1) · University of New Mexico (1) · Université de Sherbrooke (1)
Canada (4) · Spain (3) · United States (3) · Switzerland (2) · Germany (1) · Mexico (1) · Netherlands (1)
Christian F Clarenbach, MD (1) · Darryl Kaelin, MD, Medical Doctorate (US) (1) · Davin Quinn, MD (1) · Dr. Anna Lara Kattan, MD: Regenerative Medicine (1) · Katrin Bopp, Dr. (1)
PMID 16314677, PMID 32253535, PMID 32587887, PMID 32629042, PMID 32658591, PMID 32730619, PMID 32914699, PMID 35477524, PMID 36064600, PMID 37173355, PMID 39885199, PMID 42415194
2025 (1)